Drug Approval | March 30, 2022
USFDA approves CartiHeal's implant for the treatment of cartilage and osteochondral defects
Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint
